Market closed
Access this stock data via API
Subscribe
Mega Lifesciences Public Company Limited
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 15.3B 15.7B 15.7B 14.1B
Cost of revenue 7.6B 8.6B 8.6B 8.2B
Gross profit 7.8B 7.1B 7.0B 5.9B
Operating expense
Research & development 44.0M 41.3M 44.4M 40.5M
Selling general and admin 4.2B 4.0B 4.2B 3.6B
Other operating expenses
Operating income 3.4B 2.9B 2.7B 2.1B
Non operating interest income
Income
Expense 38.5M 31.3M 28.7M 28.3M
Other income expense -979.2M -611.4M -57.5M 163.7M
Pretax income 2.4B 2.3B 2.6B 2.3B
Tax provision 339.6M 269.1M 354.6M 336.0M
Net income 2.0B 2.0B 2.2B 1.9B
Basic EPS 2.3 2.3 2.6 2.2
Diluted EPS 2.3 2.3 2.6 2.2
Basic average shares 871.9M 871.9M 871.9M 871.9M
Diluted average shares 871.9M 871.9M 871.9M 871.9M
EBITDA 3.7B 3.2B 3.0B 2.5B
Net income from continuing op. 2.0B 2.0B 2.2B 1.9B
Minority interests -74K 53K 1.5M 6.0M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 4 hours 48 minutes

05:11
00:00
10:00
16:30
23:59

Trading Hours (Monday - Friday):

Main market
10:00 - 16:30
All times are displayed in the Asia/Bangkok timezone (+07, UTC+07:00).